Tag: Insulin
More Americans Will Only Have to Pay $35 a Month for Insulin in 2024
Insulin Manufacturers Employ Strategies to Extend Market Exclusivity
Strategies include filing patents after FDA approval and obtaining large numbers of patents on delivery devices
Short Sleep Duration Impairs Insulin Sensitivity in Women
Fasting insulin and HOMA-IR values were increased with sleep restriction versus maintenance of adequate sleep
Intranasal Insulin May Have Pro-Cognitive Benefits
Improvement in global cognition seen for patients with Alzheimer disease/MCI, but no effects seen for healthy individuals, other patient populations
ADA: Once-Weekly Icodec Superior for Reduction in HbA1c
Noninferior and superior reduction in HbA1c with one-weekly icodec versus once-daily degludec in insulin-naive type 2 diabetes patients
ADA: Glycemic Control Up With Weekly Icodec Versus Daily Insulin Glargine
Findings in adults with type 2 diabetes who had not previously received insulin
2012 to 2015 Saw Rise in U.S. Insulin Prices
However, introduction of new insulin products after 2015 was followed by substantial discounting practices that lowered net prices
FDA Clears New Insulin Pump and Algorithm-Based Software
Enhanced automatic insulin delivery system cleared for people with type 1 diabetes ≥6 years
DDW: Endoscopic Procedure May Eliminate Insulin Use in T2DM
Recellularization via electroporation therapy followed by GLP1-RA treatment resulted in elimination of insulin therapy for most patients
Sanofi Follows Lilly, Novo Nordisk in Cutting Insulin Prices
Sanofi is the third company to cut prices on its insulin products and cap out-of-pocket charges to $35 a month
